The results of two trials are expected to shed better light: The TB-CHAMP, in its phase III, compares Levofloxacin (15–20 mg/kg) or matching placebo for six months for child contacts of multidrug-resistant tuberculosis (5/6). https://t.co/cH1VtchR6G
2,517 followers
1,619 followers
New from #wellcometrust https://t.co/orZxCPiNRO Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)
1,619 followers
New from #The_MRC https://t.co/orZxCPiNRO Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)